Discover the full insider trade history of Hoenle AG, a listed issuer based in Germany. Shares trade on DE DE, under the oversight of BaFin. Operating in the Chemicals & Materials sector, Hoenle AG has published 1 public disclosures. Market capitalisation: €50.1m. The latest transaction was disclosed on 10 December 2025 — Buy. Among the most active insiders: Dr. Richter Vermögens- und Beteiligungsverwaltung GmbH. The full history is accessible without an account.
0 of 0 declarations
Hoenle AG is a German-listed technology company traded on Xetra/Frankfurt (DAX/MDAX/SDAX), with Germany as both its corporate base and primary operating country. For international investors, Hoenle is best understood as a focused industrial technology specialist rather than a broad diversified conglomerate. The group is active in UV technology, industrial adhesives, and UV-based disinfection solutions, and it is positioned as one of the world’s leading suppliers in this niche. Its core proposition combines systems, lamps, measurement technology, adhesives, and application-oriented services for industrial customers.([hoenle.com](https://www.hoenle.com/company/our-profile)) The company is headquartered in Gilching, near Munich, in southern Germany. It was founded in 1976 and has built its business around UV technology over several decades, initially serving industrial drying and curing applications and later expanding into bonding and disinfection. Today, Hoenle organizes its activities into three business units: Curing, Adhesive Systems, and Disinfection. This structure gives the group exposure to a broad set of end markets, including printing, converting, coatings, automotive, aerospace, consumer electronics, semiconductors, food processing, environmental technology, pharmaceuticals, and medical technology.([hoenle.com](https://www.hoenle.com/company/our-profile)) The product portfolio is centered on UV, LED-UV, IR / hot-air, and inert UV systems for industrial curing and drying, industrial adhesives and sealants, bonding and potting solutions, and disinfection systems for air, water, and surfaces. Hoenle also supplies microbiological analysis services in selected applications. A notable competitive strength is its service model: the group emphasizes worldwide field technicians, decentralized spare-parts logistics, and augmented-reality-based remote service, all of which support uptime for industrial customers.([hoenle.com](https://www.hoenle.com/company/our-profile)) From a competitive standpoint, Hoenle differentiates itself through deep technical know-how, application-specific engineering, and an integrated offering that spans equipment, consumables, and after-sales support. Management highlights more than 50 years of experience in UV technology, while the company’s international footprint includes subsidiaries in China, Korea, France, Great Britain, Austria, Malta, and the United States, plus a sales office in Italy and a wider global distributor network.([hoenle.com](https://www.hoenle.com/company/our-profile)) Recent developments suggest a business in transition but with operational improvement potential. For fiscal 2024/25, Hoenle reported sales declining to EUR 93.7 million, while EBITDA improved to EUR 5.8 million thanks to restructuring measures. For the first quarter of fiscal 2025/26, the company reported sales of EUR 21.5 million, describing a weak environment in mechanical and plant engineering, but stronger momentum in water disinfection systems. Management confirmed its 2025/26 guidance and expected a meaningful improvement in the second half of the year, supported by innovation projects, after-sales expansion, and strict cost control. In governance, a major change occurred in September 2025 when Dr. Markus Arendt left the Management Board and Dr. Franz Richter took over as CEO.([hoenle.com](https://www.hoenle.com/press-article/))